Molecular factors in the formation and development of fungal biofilms
Abstract
The aim of this review is to highlight the molecular mechanisms of formation and development of fungal biofilms, as well as promising methods of combating them.
Biofilms are a form of coexistence between representatives of one or, less commonly, different species of microorganisms. The term “fungal biofilms” refers to communities that include microscopic representatives of the Fungi kingdom — micromycetes.
The formation of a biofilm entails many advantages for its inhabitants over free-living (planktonic) forms of micromycetes. In the biofilm state, cells acquire greater resistance to physical and chemical stress factors in the environment, such as temperature fluctuations and acid-base balance. In addition, resistance to antifungal drugs (antimycotics) can increase by an order of magnitude, and in some cases by several orders of magnitude. Furthermore, within the biofilm, micromycetes become difficult to reach for the immune defence mechanisms of the host organism, which often leads to the chronicity of the infectious process.
The ability to adhere to various biotic and abiotic substrates allows microorganisms to form biofilms on the surfaces of medical devices and implants (including intravascular and urinary catheters, cardiac valve prostheses and joint endoprostheses) and on the tissues of the host organism, indicating their key role in the development of infections and persistent colonisation.
Quorum sensing, the exchange of signalling molecules using the external environment or biofilm matrix, plays an important role in biofilm formation and in the interaction of microbial cells with each other within biofilms. In recent years, a large number of diverse signalling systems based on the quorum sensing of micromycetes have been discovered, which are involved in a wide range of biological processes, including biofilm formation. Given that most microorganisms are capable of forming biofilms in their natural environment, studying their formation and functioning is one of the priority areas of modern microbiology.
About the Authors
N. AheyeuBelarus
M. Tchernovetski
Belarus
References
1. Fungal biofilm formation and its regulatory mechanism / D. Wang, N. Zeng, Ch. Li [et al.] // Heliyon. — 2024. — Vol. 10, № 12. — DOI: 10.1016/j.heliyon.2024.e32766.
2. Highlights in pathogenic fungal biofilms / J. D. C. O. Sardi, N. De S. Pitangui, G. Rodriguez-Arellanes [et al.] // Revista Iberoamericana de Micologia. — 2014. — Vol. 31, № 1. — P. 22—29.
3. Davies, D. Understanding biofilm resistance to antibacterial agents / D. Davies // Nature Reviews Drug Discovery. — 2003. — Vol. 2, № 2. — P. 114—122.
4. Production of tyrosol by Candida albicans biofilms and its role in quorum sensing and biofilm development / M. A. S. Alem, M. D. Y. Oteef, T. H. Flowers, L. J. Douglas // Eukaryotic Cell. — 2006. — Vol. 5, № 10. — P. 1770—1779.
5. Quorum Sensing in Fungal Species / X. Tian, H. Ding, W. Ke, L. Wang // Annual Review of Microbiology. — 2021. — Vol. 75, № 1. — P. 449—469.
6. Cavalheiro, M. Candida Biofilms: threats, challenges, and promising strategies / M. Cavalheiro, M. C. Teixeira // Frontiers of Medicine. — 2018. — Vol. 5. — DOI: 10.3389/FMED.2018.00028.
7. The APSES transcription factor Efg1 is a global regulator that controls morphogenesis and biofilm formation in Candida parapsilosis / L. A. Connolly, Al. Riccombeni, Z. Grozer [et al.] // Molecular Microbiology. — 2013. — Vol. 90, № 1. — С. 36—53.
8. The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans / G. Ramage, K. VandeWalle, J. L. Lopez-Ribot, B. L. Wickes // FEMS Microbiology Letters. — 2002. — Vol. 214, № 1. — P. 95—100.
9. In vitro long-term exposure to chlorhexidine or triclosan induces cross-resistance against azoles in Nakaseomyces glabratus / K. Spettel, D. Bumberger, R. Kriz [et al.] // Antimicrobial Resistance and Infection Control. — 2025. — Vol. 14, № 1. — DOI: 10.1186/s13756-024-01511-4.
10. The Membrane Activity of the Amphibian Temporin B Peptide Analog TB_KKG6K Sheds Light on the Mechanism That Kills Candida albicans / A. Kakar, L. E. Sastre-Velasquez, M. Hess [et al.] // mSphere. — 2022. — Vol. 7, № 5. — P. 1—20.
11. Mechanisms of increased resistance to chlorhexidine and cross-resistance to colistin following exposure of Klebsiella pneumoniae Clinical Isolates to Chlorhexidine / M. E. Wand, L. J. Bock, L. C. Bonney, J. M. Sutton // Antimicrobial Agents and Chemotherapy. — 2017. — Vol. 61, № 1. — P. 1—16.
12. Berman, J. Drug resistance and tolerance in fungi / J. Berman, D. J. Krysan // Nature Reviews Microbiology. — 2020. — Vol. 18, № 6. — P. 319—331.
13. WHO fungal priority pathogens list to guide research, development and public health action. — Geneva : World Health Organization, 2022. — 48 p.
14. Biofilms and Antifungal Resistance / E. P. Fox, N. Hartooni, C. J. Nobile, Sh. D. Singh-Babak’s // Antifungals: From Genomics to Resistance and the Development of Novel Agents. — Caister Academic Press, 2015. — P. 71—90. — DOI:10.21775/9781910190012.04.
15. Putative role of beta-1,3 glucans in Candida albicans biofilm resistance / J. Nett, L. Lincoln, K. Marchillo [et al.] // Antimicrobial Agents and Chemotherapy. — 2007. — Vol. 51, № 2. — P. 510—520.
16. Role of matrix β-1,3 glucan in antifungal resistance of non-albicans Candida biofilms / K. F. Mitchell, H. T. Taff, M. A. Cuevas [et al.] // Antimicrobial Agents and Chemotherapy. — 2013. — Vol. 57, № 4. — P. 1918—1920.
17. Garvey, M. Pathogenic drug resistant fungi : a review of mitigation strategies / M. Garvey, N. J. Rowan // International Journal of Molecular Sciences. — 2023. — Vol. 24, № 2. — DOI: 10.3390/ijms24021584.
Review
For citations:
Aheyeu N., Tchernovetski M. Molecular factors in the formation and development of fungal biofilms. Healthcare. 2025;1(10):45-54. (In Russ.)
